Las personas que siguen la antigua práctica del yoga podrían obtener una ventaja añadida para su salud, ya que un estudio reciente sugiere que puede rebajar la presión arterial alta, conocida también como hipertensión.
Después de más de 15 años de fracasos científicos en todo el mundo y un fraude de alto perfil, biólogos en Estados Unidos han creado células madre humanas con la misma técnica que produjo a la famosa oveja Dolly en 1996: trasplantar material genético de una célula adulta en un óvulo cuyo ADN había sido removido.
Un estudio efectuado en Canadá sugiere que cuando los pacientes con cáncer prostático responden a la terapia hormonal, lo mejor sería usar la terapia de supresión de andrógenos intermitente (TSAI).
St. Jude Medical, Inc. (St. Paul, MN) announced the commencement of enrollment in the EnligHTN III trial that will evaluate the safety and performance of the company’s second-generation EnligHTN renal denervation system in patients with drug-resistant, uncontrolled hypertension.
The Society of Cardiovascular Angiography and Interventions (SCAI) announced the presentation of data suggesting that catheter-based renal denervation is projected to improve blood pressure and substantially reduce the incidence of major cardiovascular events in patients whose high blood pressure has not been sufficiently lowered with medications. Lead Investigator Jan Pietzsch, PhD, presented the findings at the SCAI 2013 scientific sessions in Orlando, Florida.
At CX35 (6–9 April, London, UK), Cees Wittens, Maastricht, The Netherlands, presented his experience with stents for deep vein occlusive disease. He told delegates that the ideal device should offer high radial force and high flexibility.
Gerard Stansby, Newcastle, UK, told delegates at CX35 (6–9 April 2013, London, UK) that the use of glue in varicose veins in safe and effective and that, if it continues to show good results, it will be a very attractive procedure for the future.
Detailed experiences of stereotactic ablative body radiotherapy (SABR) treatments using Varian’s TrueBeam medical linear accelerator and Calypso “GPS for the Body” tumour-tracking technology were discussed at the annual European Society for Radiotherapy and Oncology (ESTRO) Forum (19–23 April 2013, Geneva, Switzerland) at the Varian Emerging Technologies Symposium.
La mayoría de los adultos mayores en Estados Unidos a los que se les diagnosticó un cáncer con el antígeno prostático específico (PSA, por su nombre en inglés) decidió someterse a un tratamiento, aún cuando los signos revelaban una enfermedad de avance muy lento, indicó un reciente estudio.
The study, which was presented at the European Society for Radiotherapy and Oncology (ESTRO) 19 to 23 April 2013, Geneva, Switzerland, used the latest cost effectiveness model to look at relevant recent data for prostate cancer. The study analysed research findings from six recent overview studies, involving 55,000 patients and looked at disease progression, associated costs and outcomes extrapolated over a ten-year time horizon from a UK National Health Service (NHS) cost perspective.
Cook Medical, on the 1 May 2013, announced it had received CE mark approval for their PVA foam embolization particles to treat benign prostatic hyperplasia. According to a company release, the PVA foam embolization particles will be shown at the Global Embolization Symposium and Technologies (GEST) 1–4 May 2013 in Prague, Czech Republic.
Las reclamaciones relacionadas con el diagnóstico (por errores en operaciones quirúrgicas o con la medicación) son las más costosas, afirman unos investigadores
In a presentation at the Society of Interventional Radiology’s Scientific Annual Meeting (13–18 April 2013, New Orleans, USA) Sandeep Bagla, Inova Alexandria Hospital, Alexandria, USA, spoke about the results of 21 patients (out of 30) who had been treated with prostatic artery embolization.
The RENOVA (Post-approval study for the Flair endovascular stent graft) results showed that stent grafts keep access sites open significantly longer in haemodialysis patients than angioplasty alone, according to a presentation given at the Society of Interventional Radiology’s (SIR) Annual Meeting (13−18 April 2013, New Orleans, USA).
At the scientific session on chemoembolization at the Society of Interventional Radiology’s Annual Meeting (13−18 April 2013, New Orleans, USA), David N Tran, UCSF, San Francisco, USA, spoke to delegates on the topic of transcatheter arterial chemoembolization in liver transplant candidates with and without marginal hepatic reserve.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos